Home › Funds › MONTANOVA CAPITAL, LLC › GLUE

MONTANOVA CAPITAL, LLC position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

MONTANOVA CAPITAL, LLC reported holding 3,549,539 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$85.9M, representing 1.57% of its reported portfolio and ranking #21 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed GLUE holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)3.55M sh
Reported value held$85.90M
Portfolio Weight1.57%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MONTANOVA CAPITAL, LLC's GLUE position evolved

MONTANOVA CAPITAL, LLC first disclosed a stake in GLUE in Q2 2024 at 2,659,000 shares (US$9.9M). The position peaked in Q2 2026 at 3,549,539 shares, worth US$85.9M. Across 9 filings, MONTANOVA CAPITAL, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 3,549,539 shares valued at US$85.9M — a reduction of -677,270 shares quarter over quarter.. Notable position changes include a 41% trim in Q4 2024 (shares fell 33% over the following quarter), a 115% increase in Q2 2025 (shares rose 64% over the following quarter), a 26% increase in Q1 2026 (shares rose 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 2.66M $9.94M New
Q3 2024 2.66M $14.09M Hold
Q4 2024 1.56M $10.85M Reduce
Q1 2025 1.56M $7.26M Hold
Q2 2025 3.36M $15.15M Add
Q3 2025 3.36M $24.90M Hold
Q4 2025 3.36M $52.68M Hold
Q1 2026 4.23M $69.53M Add
Q2 2026 3.55M $85.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has MONTANOVA CAPITAL, LLC held GLUE?

MONTANOVA CAPITAL, LLC has disclosed GLUE holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is MONTANOVA CAPITAL, LLC's current position in GLUE?

As of Q2 2026, MONTANOVA CAPITAL, LLC holds 3.55M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $85.90M, representing 1.57% of its reported portfolio and ranking #21.

Has MONTANOVA CAPITAL, LLC been buying or selling GLUE?

In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC reduced its position in GLUE. The position peaked in Q2 2026 at 3.55M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.